Two cases of multidrug-resistant recurrent endometrial cancer successfully treated with medroxyprogesterone acetate (MPA)

Japanese Journal of Cancer and Chemotherapy

Volumn 37, Issue 4, 2010, Pages 735-738

  Nishio, Shin ^a   Koyanagi, Takahiro ^a   Miyabe, Kyosuke ^a   Kuromatsu, Hajime ^a  

^a Social Insurance Tagawa Hospital   (Japan)

Author keywords

Medroxyprogesterone acetate; Recurrent endometrial cancer

Indexed keywords

ANTINEOPLASTIC AGENT; HORMONE RECEPTOR; MEDROXYPROGESTERONE ACETATE;

ARTICLE; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER STAGING; CASE REPORT; DISEASE FREE INTERVAL; ENDOMETRIOID CARCINOMA; FEMALE; HUMAN; LUNG METASTASIS; MODERATELY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA; MULTIDRUG RESISTANCE; POORLY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA; POSTOPERATIVE CARE; RECURRENT CANCER; SMALL INTESTINE METASTASIS; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT; UTERUS CARCINOMA; VISCERAL METASTASIS;

EID: 79960778270     PISSN: 03850684     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (9)

1. Kelley RM and Baker WH: Progestational agents in the treatment of carcinoma of the endometrium. N Engl J Med 264: 216-222, 1961.
2. Kauppila A: Progestin therapy of endometrial, breast and ovarian carcinoma. A review of clinical observations. Acta Obstet Gynecol Scand 63(5): 441-450, 1984.
3. Podratz KC, O'Brien PC, Malkasian GD Jr, et al: Effects of progestational agents in treatment of endometrial carcinoma. Obstet Gynecol 66(1): 106-110, 1985. (Pubitemid 15047395)
4. Lentz SS, Brady MF, Major FJ, et al: High-dose megestrol acetate in advanced or recurrent endometrial carcinoma: a Gynecologic Oncology Group Study. J Clin Oncol 14(2): 357-361, 1996. (Pubitemid 26050995)
5. Thigpen JT, Brady MF, Alvarez RD, et al: Oral medroxyprogesterone acetate in the treatment of advanced or recurrent endometrial carcinoma: a dose-response study by the Gynecologic Oncology Group. J Clin Oncol 17(6): 1736-1744, 1999. (Pubitemid 29269242)
6. Ushijima K, Yahata H, Yoshikawa H, et al: Multicenter phase II study of fertility-sparing treatment with medroxyprogesterone acetate for endometrial carcinoma and atypical hyperplasia in young women. J Clin Oncol 25(19): 2798-2803, 2007. (Pubitemid 47123189)
7. Kaku T, Yoshikawa H, Tsuda H, et al: Conservative therapy for adenocarcinoma and atypical endometrial hyperplasia of the endometrium in young women: central pathologic review and treatment outcome. Cancer Lett 167(1): 39-48, 2001. (Pubitemid 32373267)
8. Niwa K, Tagami K, Lian Z, et al: Outcome of fertility-preserving treatment in young women with endometrial carcinomas. BJOG 112(3): 317-320, 2005. (Pubitemid 40314007)
9. http://www.nccn.org/professionals/physician-gls/f-guidelines.asp